Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach carcinoma  by Guo, Xiu-Li et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2015; 8(9): 724–730724Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2015.07.020*Corresponding author: You-Qing Xu, PhD., Attending Physician, Department
of Digestive System, Beijing Tiantan Hospital, Capital Medical University, Beijing
100050, China.
Tel: +86 13552212981
E-mail: youqingxuu@hotmail.com
Peer review under responsibility of Hainan Medical University.
Foundation project: It is supported by The National Science Fund for Distin-
guished Young Scholars (No.: 0602150028).
1995-7645/Copyright © 2015 Hainan Medical College. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an open
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach
carcinomaXiu-Li Guo1, Ya-Jie Wang2, Pei-Lin Cui1, Yan-Bin Wang1, Pi-Xia Liang1, Ya-Nan Zhang3, You-Qing Xu1*1Department of Digestive System, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
2Central Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
3Department of Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, ChinaARTICLE INFO
Article history:
Received 15 Jun 2015
Received in revised form 20 Jul 2015
Accepted 20 Jul 2015
Available online 29 July 2015
Keywords:
BRMS1
Proliferation
Migration
Adhesion
Forestomach carcinoma
MiceABSTRACT
Objective: To discuss the effect of BRMS1 on the proliferation, migration and adhesion
of mouse forestomach carcinoma.
Methods: The constructed pCMV-myc-BRMS1 recombinant plasmid and blank plasmid
were transfected into mouse forestomach carcinoma. MTT method was employed to
measure the activity of gastric cancer cell; the scratch assay and Transwell assay to
measure the migration and invasion of gastric cancer cell; the adhesion assay to measure
the adhesion of gastric cancer cell; while the Western blot assay to measure the
expression of The NF-kB signal pathway, downstream matrix metalloproteinase (MMP)-
2, MMP-9 and osteopontin and E-cadherin in the gastric cancer cell. Besides, the
transplanted animal model of gastric cancer in mice was constructed to measure the size
of tumor xenograft.
Results: Results of MTT assay showed that, compared with the empty vector control
group, the activity of gastric cancer cell was not affected in the BRMS1 transfection
group. The improved expression of BRMS1 could inhibit the adhesion, migration and
invasion of gastric cancer cell (P < 0.01). Besides, compared with the empty vector
control group, the phosphorylation of NF-kB p65 and IkBa was reduced in the BRMS1
transfection group, with the decreased expression of MMP-2, MMP-9 and osteopontin
and the increased expression of E-cadherin (P < 0.01). Results of animal experiment also
showed that the expression of BRMS1 did not affect the transplanted tumor.
Conclusions: The expression of BRMS1 can signiﬁcantly inhibit the adhesion, migra-
tion, invasion and metastasis of mouse forestomach carcinoma gastric cancer cell, which
is related to The NF-kB signal pathway.1. Introduction
The tumor metastasis suppressor gene is some kind of gene
related to the tumor, with the high expression in the non-
metastatic tumor and low expression in the metastatic one.
As it does not affect the growth of tumor, it is regarded as the
one to inhibit the metastasis of tumor. The breast cancermetastasis suppressor 1 (BRMS1) is the tumor metastasis
suppressor gene that was found on human chromosome 11 in
2000. The subsequent researches also indicated the low
expression of BRMS1 gene in many tumors such as the breast
cancer, malignant melanoma and bladder cancer, with the
certain inhibition against the metastasis of tumor [1,2]. For
instance, Cicek et al. [1] transfected BRMS1 into MDA-MB-
231 and MDA-MB-435 of breast cancer cells, which could
reduce the performance of metastasis by 50%–90%. Samant
et al. [2] also transfected BRMS1 into MDA-MB-231 of breast
cancer cells to reduce the performance of metastasis by 70%–
90%. Meanwhile, it was also found that when injecting the
MDA-MB-231 and MDA-MB-435 of breast cancer cells with
the transfected BRMS1 gene into the nude mouse mammaryaccess article under the CC BY-NC-ND
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was signiﬁcantly reduce, which fully showed that the
expression of BRMS1 could deeply affect the metastasis of
tumor.
Liu et al. [3] transfected BRMS1 shRNAs into the non-small
cell lung cancer, which could promote the migration of cells
and enhance the transcriptional activity of NF-kB RelA/p65.
Cicek et al. [4] transfected BRMS1 into the human melanoma
cell line C8161.9 and found the negative correlation between
the expression of BRMS1 and binding activity of NF-kB.
BRMS1 could rely on The NF-kB signal pathway to regulate
the expression of OPN and thus affect the metastasis of
breast cancer and the tumor of animal model of glioma [5].
Sheng et al. [6] performed the experiments of RT-PCR and
WB and found that the knockout of BRMS1 from OVCAR3 of
breast cancer cells could signiﬁcantly improve the migration
and invasion of cells, which was related to the improved
expression of NF-kB p65 and osteopontin. The overexpression
of BRMS1 in glioma cells could signiﬁcantly down-regulate
the expression of NF-kB and inhibit the expression and ac-
tivity of matrix metalloproteinase (MMP)-2 and MMP9 and
thus inhibit the adhesion, migration and invasion of cancer
cells [7]. In the gastric cancer cell SGC-7901 and transplanted
tumor model of gastric cancer, the activity of NF-kB was
negatively relative to the expression of E-cadherin [8,9]. It thus
indicated that BRMS1 could affect the process of migration,
invasion, adhesion and metastasis of tumor cells through The
NF-kB signal pathway and then regulate the expression of
related proteins.
The expression of BRMS1 was signiﬁcantly reduced or lost
in the gastric cancer, which was negatively related to the
metastasis of lymph node [10]. But the speciﬁc mechanism of
inhibition against the metastasis of gastric cancer has been
unknown. Under such background, we constructed the
mouse forestomach carcinoma strains with the
overexpression of BRMS1 and then performed MTT assay
and experiments of adhesion, migration and invasion to
discuss the effect of expression of BRMS1 on the
proliferation, adhesion, migration and invasion of mouse
forestomach carcinoma gastric cancer cell strains. Besides,
Western blot assay was employed to measure The NF-kB
signal pathway and the expression of downstream proteins
MMP-2, MMP-9, osteopontin, and E-cadherin. Finally, the
transplanted animal model of gastric cancer in mice was
constructed to measure the effect of expression of BRMS1 on
the size of transplanted tumor.
2. Materials and methods
2.1. Materials and reagents
The mouse forestomach carcinoma was purchased from The
Cell Bank of Type Culture Collection of Chinese Academy of
Sciences, with the item No. of 31800022; the tetrazolium salt
(MTT) from Sigma; the rabbit anti MMP-2, MMP-9, osteo-
pontin and E-cadherin antibodies from Epitomics; the rabbit
anti NF-kB p65, p-NF-kB p65, IkBa and p-IkBa antibodies
from Cell Signaling Technology; the Transwell chamber from
Corning; the fetal bovine serum, RPMI-1640 medium and
trypsin from Gbico; the crystal violet from Sigma; CO2 incu-
bator from Thermo Scientiﬁc; the inverted microscope from
Nikon; dual mini vertical electrophoresis apparatus, minitransfer electrophoresis apparatus and ChemiDoc™ XRS sys-
tem from Bio-Rad.
2.2. Construction of BRMS1 eukaryotic expression
vector
The gene sequence of BRMS1 was searched in GeneBank
and then the primer was designed with the sequence: upstream
50-ATGCCTGTCCAGCCTCCAAG-30, 50-GCGTCGCTCA-
TAGTCCTCATCA-30. The target fragment was extracted using
Trizol method, while PCR for the ampliﬁcation of target frag-
ment and electrophoresis for the detection of target product. The
double digestion and link was performed, being followed by the
plasmid transformation and extraction, and then PCR screening,
identiﬁcation by restriction analysis and sequencing, ﬁnally
obtain the BRMS1 eukaryotic expression vector.
2.3. Measurement of cell proliferation rate using MTT
method
Cells were seeded onto 96-well plate, with 200 mL in each
well respectively. When the conﬂuency of cells reached to
70%, it was to transfect pCMV-myc-BRMS1 recombinant
plasmid and blank plasmid. 48 h after the transfection, 20 mL
5 mg/mL MTT was added for the continuous culture of 4 h and
then the culture medium was sucked out. Afterwards, 150 mL
DMSO was added in each well and then it was shaken to fully
dissolve the crystals. CD value was measured at 560 nm of
analyzer of enzyme-linked immunosorbent assay, while
630 nm was chosen as the reference wavelength to calculate the
proliferation rate.
2.4. Scratch assay
Cells were seeded onto 6-well plate. When the conﬂuency
of cells reached to 70%, it was to transfect pCMV-myc-
BRMS1 recombinant plasmid and blank plasmid respectively.
48 h after the transfection, 20 mL pipette gun head was
employed to scratch on 6-well plate. It was then washed by
PBS for three times. Afterwards, the serum-free RPMI-1640
was chosen for the culture, which was observed under Nikon
inverted microscope. The scratch width was measured and
photographed.
2.5. Cell adhesion assay
48 h after the cell culture with the terminated transfection,
each group of cells was collected. The cell concentration was
adjusted to 1 × 105, which was seeded on 96-well plate that was
coated by Matrigel (50 mg/mL). Inadhesive cells were washed
off, while the absorbance value of each well at 570 nm was
measured using MTT method. The optical density could be
used to reﬂect the ratio of cells adhered to Matrigel on 96-well
plate, with the calculation equation: Optical density value of
cells adhered to Matrigel/optical density value of total
cells × 100%.
2.6. Cell invasion assay
Matrigel basement membrane was evenly paved on the
micromembrane (5 mm) of Transwell chamber to be prepared as
Figure 1. Effect of BRMS1 on adhesion of mouse forestomach carcinoma.
Xiu-Li Guo et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(9): 724–730726the gel for further use. Cells were seeded onto 96-well plate,
with 100 mL in each well. When the conﬂuency of cells reached
to 70%, it was to transfect pCMV-myc-BRMS1 recombinant
plasmid and blank plasmid. 48 h after the transfection, cells were
digested and added in the upper chamber of Transwell, while the
lower chamber contained DEME medium with 5% fetal bovine
serum for the further 24 h of culture. Then the Transwell
chamber was taken out and washed, using the paraformaldehyde
for the ﬁxation. It was then stained with the crystal violet and the
stained cytoplasm appeared to be purple. The number of
membrane-penetrating cells in ﬁve ﬁelds was counted under the
inverted optical microscope and the mean number of cells for
each ﬁeld was calculated to represent the invasion ability of
cells.
2.7. Western blot assay
Cells were seeded onto 96-well plate, with 100 mL in each
well. When the conﬂuency of cells reached to 70%, it was to
transfect pCMV-myc-BRMS1 recombinant plasmid and blank
plasmid. 48 h after the transfection, cells were scraped and
centrifuged. Then RIPA lysis buffer was added with the
certain quantity. It was put in Vortex instrument for 30 s of
shaking every 10 min. After 40 min, it was centrifuged at 4 C
and 10000 rpm for 10 min. The supernatant was sucked
carefully to obtain the total protein. The protein concentration
was measured with BCA kit. The protein loading buffer was
treated with SDS gel electrophoresis and then it was trans-
ferred with the wet method. Then the ﬁlm was immersed into
the primary antibody solution for the incubation at 4 C over
night. After being washed, it was immersed into the secondary
antibody solution (1:100) for the incubation at the room
temperature for 1–2 h. Afterwards, the ﬁlm was taken out and
washed, while ECL reagent was added on the ﬁlm for the
exposure in the gel imaging system. Statistics was performed
on the gray value of each antibody band using ‘Quantity one’
software.
2.8. Nude mice test
40 nude mice were divided into 2 groups, with 20 subjects in
each one respectively. The empty vector control group was
injected with the gastric cancer cells that contained the blank
plasmid, while the BRMS1 transfection group was injected with
the gastric cancer cells that contained the BRMS1 recombinant
plasmid. On the day before the cell transfection, cells were
seeded on 10 cm culture dish, with 12 dishes in total. On the
next day, it was to transfect pCMV-myc-BRMS1 recombinant
plasmid and blank plasmid. Cells were collected after 24 h. The
cell concentration was regulated to 3 × 106 cells per 100 mL.
Afterwards, it was transferred to a sterile EP tube and then
injected into right skin of nude mice. Beginning from the 7th
day, the size of tumor was measured every 3 days, which was
expressed as the tumor volume.
2.9. Data analysis
The results were expressed as mean ± SD, with three repeats
for each set of data at least. The t test was employed and
P < 0.05 was meant to be signiﬁcant difference. All data were
analyzed using SPSS 17.0.3. Results
3.1. Effect of BRMS1 on activity of mouse forestomach
carcinoma
There was no signiﬁcant difference in the activity of gastric
cancer cells between BRMS1 transfection group and empty
vector control group (P > 0.05), with the value of 1.00 ± 0.12
and 0.96 ± 0.05, respectively.
3.2. Effect of BRMS1 on adhesion of mouse forestomach
carcinoma
As shown in Figure 1, according to MTT assay, compared
with the empty vector control group, the adhesion of gastric
cancer cells in BRMS1 transfection group was reduced, with the
statistical signiﬁcant difference (P < 0.01).
3.3. Effect of BRMS1 on migration and invasion of
mouse forestomach carcinoma
As shown in Figure 2, the migration distance of cells in
BRMS1 transfection group and empty vector control group was
(32.48 ± 2.09) mm and (52.38 ± 2.57) mm respectively, with the
statistical difference (P < 0.01). As shown in Figure 3, the
number of gastric cancer cells that penetrated through the lower
chamber in BRMS1 transfection group and empty vector control
group was 59.68 ± 9.27 and 99.37 ± 8.02 respectively, with the
statistical signiﬁcant difference (P < 0.01).
3.4. Effect of BRMS1 on expression of MMPs in mouse
forestomach carcinoma
After transfecting BRMS1 recombinant plasmid and blank
plasmid in the mouse forestomach carcinoma, results showed
that, compared with the control group, the expression of MMP-2
and MMP-9 was signiﬁcantly down-regulated in BRMS1 trans-
fection group, with the statistical signiﬁcant difference
(P < 0.01), as shown in Figure 4.
3.5. Effect of BRMS1 on expression of osteopontin and
E-cadherin in mouse forestomach carcinoma
After transfecting BRMS1 recombinant plasmid and blank
plasmid in the mouse forestomach carcinoma, results showed
that, compared with the control group, the expression of osteo-
pontin was down-regulated and the expression of E-cadherinCompared with the empty vector control group, P < 0.01.
Figure 2. Effect of BRMS1 on migration of mouse forestomach carcinoma.
A: Empty vector control group, B: BRMS1 transfection group.
Figure 3. Effect of BRMS1 on invasion of mouse forestomach carcinoma.
A: Empty vector control group, B: BRMS1 transfection group.
Figure 4. Effect of BRMS1 on expression of MMPs in mouse forestomach carcinoma.
Compared with the empty vector control group, P < 0.01.
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tical signiﬁcant difference (P < 0.01), as shown in Figure 5.
3.6. Effect of BRMS1 on NF-kB signal pathway in mouse
forestomach carcinoma
After transfecting BRMS1 recombinant plasmid and blank
plasmid in the mouse forestomach carcinoma, results showed that,
compared with the control group, the phosphorylation of NF-kBFigure 5. Effect of BRMS1 on expression of osteopontin and E-cadherin in m
Compared with the empty vector control group, P < 0.01.p65 and IkBa was reduced in BRMS1 transfection group, with the
statistical signiﬁcant difference (P < 0.01), as shown in Figure 6.
3.7. Effect of BRMS1 on size of transplanted tumor of
nude mice with gastric cancer
After the subcutaneous injection of mouse forestomach car-
cinoma gastric cancer cells, the tumor size was measured since
the 7th day and every 3 days. Except the 13th and 19th days,ouse forestomach carcinoma.
Figure 6. Effect of BRMS1 on NF-kB signal pathway in mouse forestomach carcinoma.
Compared with the empty vector control group, P < 0.01.
Figure 7. Effect of BRMS1 on size of transplanted tumor of nude mice with gastric cancer.
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signiﬁcant change in the size of transplanted tumor in BRMS1
transfection group, as shown in Figure 7 (the left ﬁgure began
from the 13th day).
4. Discussion
When transfecting BRMS1 in the human melanoma cell line
C8161.9, results showed that the tumor formation of melanoma
cell was not affected, but the metastasis of melanoma was
signiﬁcantly inhibited [11]. Furthermore, when BRMS1 plasmid
was transfected into epithelial ovarian cancer cell lines HO-
8910PM, results showed that the expression of BRMS1 would
not affect the growth of cancer cells in vitro or primary tumor
in vivo, but it could signiﬁcantly inhibit the adhesion of cancer
cells and extracellular matrix [12]. BRMS1 was transfected in the
lung cancer cells NCI-H1299 and thus the animal model of lung
cancer was constructed. Results of the in vitro and in vivo tests
all showed that BRMS1 could signiﬁcantly inhibit the metastasis
of NCI-H1299 cells, but not affect the growth of primary tumor
[13]. This study also proved that the expression of BRMS1 would
not affect the activity of mouse forestomach carcinoma cells or
change the size of transplanted gastric cancer. It indicated that
the expression of BRMS1 could signiﬁcantly affect the
invasion and metastasis of cancer cells, but not affect its
growth, while the speciﬁc mechanism had been unknown. The
key step to the dynamic process of invasion and metastasis of
tumor cells was how to penetrate through the biological
containments. The adhesion molecule was to mediate the
adhesion of cancer cells and basement membrane or
extracellular matrix and then induce the tumor cells to release
or activate multiple proteolytic enzymes to degrade the
basement membrane and extracellular matrix. Finally, under
the combined action of multiple cytokines, it was migrated to
the target tissue for the clonal proliferation to form the
metastasis. Therefore, it could also be regarded that BRMS1
could inhibit the adhesion, migration and invasion of tumor
cells and thus inhibit the metastasis of tumor.NF-kB is the transcription factor of cell nucleus, which is
closely related to the apoptosis, invasion and metastasis of tumor
cells. In case of the external stimulation, it can be separated from
IkB and then be transplanted in the nucleus to be integrated with
the target gene, which could play the role of transcription and
regulation, drive the occurrence of molecular mechanisms
related to the adhesion, invasion and metastasis of tumor,
regulate the expression of proteins of E-cadherin, osteopontin
and MMPs and thus promote the mobility and invasion of cancer
cells. According to Long et al. [14], the expression of NF-kB was
decreased gradually in the human gastric cancer tissues,
paracarcinoma tissues and normal tissues. The opinion that
BRMS1 could inhibit the activity of NF-kB to inhibit the
metastasis of tumor was supported by many researches [3–
5,15,16]. As Liu et al. [3] found that BRMS1 could be co-
immunoprecipitated with RelA/p65, the subunit of NF-kB.
Findings of Cicek et al. [17] also showed that BRMS1 could
inhibit the phosphorylation of IkBa, as well as The NF-kB
nuclear transportation and activation. Li et al. [15] held that
NF-kB inhibitor could inhibit the invasion of gastric cancer
cell and NF-kB signal transduction pathway, which could be
used as the potential treatment strategy for the gastric cancer.
This study also proved that the phosphorylation of NF-kB p65
and IkBa was reduced in BRMS1 recombinant plasmid
transfection group.
BRMS1 could inhibit the reconstruction of cytoskeleton and
the formation of cell adhesion protein [18]. The osteopontin is
some kind of secretory phosphorylated glycoprotein, which
can be interacted with the extracellular matrix and then used
as the signal molecule to be involved in the cell adhesion,
migration, immune reaction and inﬂammatory reaction.
BRMS1 shows the negative correlation with the osteopontin in
the hepatocellular carcinoma cells. Besides, BRMS1 would not
affect the growth of SK-Hep1 cells, while BRMS1 transfection
could signiﬁcantly inhibit the expression of osteopontin [19]. The
high metastasis of BRMS1 contributed to the increased
expression of osteopontin in the glioma cell lines [20]. The
transfection of osteopontin RNAi in the gastric cancer cell
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invasion of gastric cancer cells and down-regulate the expression
of MMP-2 and binding activity of NF-kB DNA. The in vivo
animal experiments also proved that, compared with the wild
mice, the osteopontin siRNA could signiﬁcantly inhibit the
growth of tumor and prolong the survival of mice [21]. The gene
silencing of osteopontin could signiﬁcantly inhibit the growth,
invasion and metastasis of tumor in the transplanted tumor
mice model with gastric cancer and also down-regulate the
expression of MMP-2 and MMP-9 through The NF-kB signal
pathway [22]. This study also proved the down-regulated
expression of osteopontin in BRMS1 recombinant plasmid
transfection group, which indicated that BRMS1 could regulate
the expression of osteopontin through The NF-kB signal
pathway and thus inhibit the adhesion and invasion of gastric
cancer cells.
E-cadherin is the transmembrane protein on the cell surface,
as some kind of epithelial cadherin, which can medicate the
adhesion among same cells and between cells and play the key
role in maintaining the cellular morphology, signal transduction
and integrity of tissue structure. E-cadherin is regarded as the
selective adhesive of epithelial cells and its down-regulated
expression or missing will dissociate the epithelial cells and
thus cause the dissociation of malignant tumor from the primary
focus during the metastasis and result in the metastasis and
spread of tumor cells. The missing or down-regulated expression
of E-cadherin can promote the malignancy of gastric cancer and
suggest a bad prognosis for patients with tumor [23]. The
interference expression of E-cadherin in the ovarian cancer
cell RMUG-S could signiﬁcantly promote the adhesion and in-
vasion of cancer cells [24]. When transplanting the E-cadherin
gene in the tumor cells with the high level and stable
expression, it could reduce or disappear the invasion of tumor
cells [25]. In the gastric cancer cell SGC-7901, the expression
of E-cadherin could be inhibited through The NF-kB signal
pathway and thus the adhesion and metastasis of cancer cells
could be improved [26]. This study also proved the up-regulated
expression of E-cadherin in the BRMS1 recombinant plasmid
transfection group, which indicated that BRMS1 could regulate
the expression of E-cadherin through The NF-kB signal pathway
and thus inhibit the adhesion and invasion of gastric cancer cells.
The degradation of extracellular matrix is the essential step
for the invasion and metastasis of tumor. MMPs are the most
important group of proteinases in the degradation of extracel-
lular matrix, which plays the critical role in the invasion and
metastasis of cell tumor and is also the key enzyme in these
processes. MMP-9 is some kind of proteolytic enzyme secreted
by various cells, as the enzyme with the largest molecular weight
among MMPs, which can degrade the extracellular matrix and
basement membrane, improve the movement of cells and pro-
mote the spread and metastasis of tumor. MMPs played the
critical role in the invasion of hepatocellular carcinoma cells [27].
Yang et al. [28] found the signiﬁcantly over-expression of MMP-
9 in the gastric cancer tissue, while the expression of MMP-9 in
patients with the distant metastasis was signiﬁcantly higher than
the one in patients without the distant metastasis. According to
the clinical meta analysis, the high expression of MMP-9 could
promote the invasion of gastric cancer tissues and then affect the
prognosis of patients with the gastric cancer [29]. In pathological
conditions, there was the positive correlation between the
activation of NF-kB and the expression of MMP-2 and MMP-
9, which could affect the growth, proliferation, invasion andmetastasis of tumor [30,31]. MMP-2 could not only degrade the
gelatin and type IV collagen in the extracellular matrix that
contributed to the inﬁltration of tumor cells along the damaged
basement membrane around, but also promote the invasion and
metastasis of tumor through the new capillaries, as the indicator
for the inﬁltration and invasion of malignant tumor [32]. Kwon
et al. [33] proved that MMP-2 siRNA could inhibit the migra-
tion of gastric cancer cells and it was realized through The NF-
kB signal pathway. This study also proved the down-regulated
expression of MMP-2 and MMP-9 in BRMS1 recombinant
plasmid transfection group and indicated that BRMS1 could
regulate the expression of MMP-2 and MMP-9 through The NF-
kB signal pathway and thus inhibit the invasion and metastasis
of gastric cancer cells.
In conclusion, the expression of BRMS1 does not affect the
activity of mouse forestomach carcinoma or the size of trans-
planted tumor of nude mice. The increased expression of BRMS1
can inhibit the adhesion, migration and invasion of gastric
cancer cells. Such process is related to the down-regulated
expression of osteopontin, MMP-2 and MMP-9 and the up-
regulated expression of E-cadherin, which may be realized
through The NF-kB signal pathway.
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